(Q38054578)

English

Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis

scientific article published on 23 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

0 references

Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis (English)

1 reference

Europe PubMed Central

27 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jian Chen

1

1 reference

Europe PubMed Central

27 August 2017

Yun Ye

2

1 reference

Europe PubMed Central

27 August 2017

Haozhen Sun

3

1 reference

Europe PubMed Central

27 August 2017

Genming Shi

4

1 reference

Europe PubMed Central

27 August 2017

publication date

23 October 2012

1 reference

Europe PubMed Central

27 August 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

27 August 2017

71

1 reference

Europe PubMed Central

27 August 2017

265-272

1 reference

Europe PubMed Central

27 August 2017

1

1 reference

Europe PubMed Central

27 August 2017

https://scigraph.springernature.com/pub.10.1007/s00280-012-2005-9

0 references

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2005-9

21 January 2018

Identifiers

10.1007/S00280-012-2005-9

1 reference

Europe PubMed Central

27 August 2017

Dimensions Publication ID

0 references

release_zqlocjfvebczbhu5f7q246tdza

1 reference

https://api.fatcat.wiki/v0/release/zqlocjfvebczbhu5f7q246tdza

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38054578&oldid=1843690784"